Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients.
D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D003365:Costs and Cost Analysis; D015942:Factor VIIa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011356:Product Labeling; D016032:Randomized Controlled Trials as Topic
D015942:Factor VIIa